At the 35th session of 7th directorate meeting held on February 7, 2014, Zhongyuan Union Stem Cell Bio-engineering Corporation discussed and approved the appointment of Wu Mingyuan as General Manager.
Vcanbio Cell & Gene Engineering Corp., Ltd
Equities
600645
CNE000000545
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.2 CNY | -1.04% | -2.66% | -15.15% |
1st Jan change | Capi. | |
---|---|---|
-15.15% | 1.11B | |
-5.37% | 12.35B | |
-3.75% | 8.17B | |
+7.79% | 5.77B | |
+33.10% | 5.65B | |
-12.12% | 4.1B | |
+14.18% | 2.67B | |
-5.70% | 2.31B | |
+18.60% | 2.02B | |
-6.70% | 1.81B |
- Stock Market
- Equities
- 600645 Stock
- News Vcanbio Cell & Gene Engineering Corp., Ltd
- Zhongyuan Union Stem Cell Bio-Engineering Corporation Appoints Wu Mingyuan as General Manager